A carregar...
Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
BACKGROUND: Cisplatin-based chemotherapy is the first-line treatment for ovarian cancer. However, acquired resistance to cisplatin treatment often occurs in epithelial ovarian cancer, and effective and practical methods for overcoming this obstacle are urgently needed. The study aimed to demonstrate...
Na minha lista:
| Publicado no: | J Ovarian Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6839134/ https://ncbi.nlm.nih.gov/pubmed/31703731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-019-0570-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|